Search
Close this search box.

Trials

N-of-1 Trials to Promote Deprescribing

October 1, 2024 at 2PM ET | 11AM PT Presenter: Dr. Parag Goyal, Associate Professor of Medicine at Weill Cornell Medicine, Division of Cardiology and the Division of General Internal Medicine Description: This webinar outlined the potential value of N-of-1 trials as an innovative strategy to promote deprescribing (and more broadly, shared decision making). Suitability as […]

N-of-1 Trials to Promote Deprescribing Read More »

EQUIPPED for Age-Friendly Prescribing in the Emergency Department

July 18, 2023 at 2PM ET | 11AM PT Presenter: Dr. Camille Vaughn Description: Dr. Vaughan discussed the evaluation of the EQUIPPED medication safety program from its beginnings as a single site quality improvement initiative to a cluster-randomized implementation trial. Since 2012, the EQUIPPED program has been implemented in 20 VA medical centers and 5 non-VA health

EQUIPPED for Age-Friendly Prescribing in the Emergency Department Read More »

Results of the MedSafer Study: Deprescribing Trials and Tribulations

April 4, 2023 at 2PM ET | 11AM PT Presenter: Dr. Emily McDonald  Description: Dr. McDonald will present the MedSafer Study which tested a software that guided clinicians through the process of deprescribing for older adults with polypharmacy during an acute care hospitalization. The webinar will present the results of the MedSafer study, the largest randomized

Results of the MedSafer Study: Deprescribing Trials and Tribulations Read More »

Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial

Elizabeth Bayliss, MD, MSPHSenior Investigator, Institute for Health Research, Kaiser Permanente ColoradoProfessor of Family Medicine, University of Colorado School of MedicineIMPACT Health Care Systems (HCS) CoreUSDeN Data and Resources Core Co-LeaderUSDeN Measures Working Group Leader Cynthia Boyd, MD, MPHDirector, Division of Geriatric Medicine and GerontologyProfessor of Medicine, Epidemiology and Health Policy and ManagementJohns Hopkins University

Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial Read More »

Beyond Study Design and Primary Outcomes: Lessons Learned from a Deprescribing Trial to Increase Cognitive Reserve

Presenter: Dr. Daniela Moga is an Associate Professor and Larry H. Spears Endowed Chair in Pharmacogenetics in the College of Pharmacy at University of Kentucky. April 12, 2022 | 2PM ET / 11AM PT The course of Alzheimer’s disease (AD) includes a 10–20-year preclinical period with progressive accumulation of amyloid β plaques and neurofibrillary tangles

Beyond Study Design and Primary Outcomes: Lessons Learned from a Deprescribing Trial to Increase Cognitive Reserve Read More »

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.